Asthma Risk Doubles in People With Diabetes
By Dennis Thompson HealthDay Reporter
TUESDAY, Sept. 10, 2024 -- People with type 2 diabetes are nearly twice as likely to develop asthma, a new review has concluded.
Type 2 diabetics are 83% more likely to develop asthma, compared to those without diabetes, researchers found.
The relationship also works the other way around -- people with asthma are 28% more likely to develop type 2 diabetes, researchers report.
“This relationship emphasizes the need for greater awareness among patients with type 2 diabetes or asthma and their healthcare providers,” said lead researcher Dr. Nam Nguyen with Taipei Medical University in Taiwan.
For the study, researchers pooled data on 17 million people from 14 prior studies examining the link between asthma and type 2 diabetes.
The results also showed that the more severe a person’s asthma is, the higher their risk of type 2 diabetes, researchers report.
These findings suggest that asthma and diabetes might have some of the same underlying causes, or have other factors in common, researchers said.
Nguyen said future studies should look into the potential links between asthma and type 2 diabetes.
Researchers presented the study Monday at the European Association for the Study of Diabetes annual meeting in Madrid. Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.
“Preventive strategies should be considered to lower the risk of type 2 diabetes in individuals with asthma,” Nguyen said in a meeting news release. “For instance, screening for and addressing pre-diabetes in asthma patients promptly before it develops into type 2 diabetes, or carefully managing the use of systemic corticosteroids, which can not only cause temporary hyperglycemia but are also linked to an increased risk of type 2 diabetes.”
Sources
- European Association for the Study of Diabetes, news release, Sept. 9, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
FRIDAY, May 23, 2025 — A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count...
Cities Contribute To Asthma, Researchers Argue
FRIDAY, May 23, 2025 — Dirty, crowded urban environments can significantly increase a person’s risk of developing asthma, a new study says. Cleaner...
GLP-1 Drugs Appear To Lower Cancer Risk
MONDAY, May 19, 2025 — Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.